focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
News is imminent
Our clinically proven, highly effective, EU approved Erectile Dysfunction product - Eroxon - will be launched, marketed and available for purchase without prescription…
Sales are likely to be spectacular
SP should ??
With a successful marketing campaign there will be no stopping this share.
For those who bang on about Vicks and KY … go try (particularly the Vicks).
We are now just in a final holding pattern as we await news for who we are partnering with in EU/UK
Exciting times
proven to be highly effective and bound to create explosive sales as marketing starts and the product becomes available in europe and across the globe.
I imagine the whining and relentless repetition of unenthusiastic nonsense will cease here quickly once the product is flying off the shelves
SP upside immense
Lets ‘hope’ the breakout is in the right direction and that we see 60 (again) before we see 5 (again). Many seem to be anticipating stormy markets ahead.Stocks with just hope to hold them up can struggle in turbulent environments.
Most experts believe Covid vaccines will be ineffective within 1 YEAR
https://mol.im/a/9419815
There can not be that many opportunities to invest in a small company with just so much potential. Potential to save, extend and enhance millions (even billions) of lives. Potential, too, to multiply investment.
Universal Corona Vaccine
Suite of Cancer beating platforms
SCIB1
SCIB2
Moditope
Cash in the bank, the world is watching